Abstract: The present invention relates to paste-like masses that can be used in electrochemical elements, comprising a heterogeneous mixture of (A) a matrix containing or comprising at least one organic polymer, precursors thereof, or prepolymers thereof, (B) an electrochemically activatable inorganic or largely inorganic liquid that does not dissolve the matrix or essentially does not dissolve the matrix, and, if required, (C) a powdery solid that is essentially inert relative to the electrochemically activatable liquid.

Abstract: Disclosed is a DNA polynucleotide comprising a nucleic acid sequence having promoter activity in a Drosophila S2 cell, where said nucleic acid sequence is selected from (i) a nucleotide sequence of SEQ ID NO: 1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO: 5, SEQ ID NO:6, SEQ ID NO:33, SEQ ID NO:36, SEQ ID NO: 37, or SEQ ID NO: 68 with or without flanking restriction site sequences at either terminus; (ii) a functional nucleotide sequence with a sequence identity of at least 80% to any one sequence of (i); (iii) a nucleotide which is a functional fragment of at least 6 contiguous nucleotides of any one sequence of (i) or (ii); (iv) a functional nucleotide sequence with a sequence identity of at least 80% to said functional fragment of (iii); (v) a first chimeric nucleotide sequence comprising two or more sequences of any one sequence of (i), (ii), (iii) and (iv), and (vi) a second chimeric nucleotide sequence, comprising at least 6 nucleotides and including consecutive nucleotide stretches from at least

Abstract: The invention relates to a paste-like mass that can be used in electrochemical structural elements, including a heterogeneous mixture of (1.) a matrix (A) containing at least one organic polymer, precursors thereof, or prepolymers thereof, or consisting of said components, (2.) an electrochemically activatable inorganic material in the form of a solid substance (B), said material not being soluble in said matrix and in water, and (3.) a material (C) which is capable of improving the transport of a liquid electrolyte into and the storage thereof within the structural element, with the proviso that said material (C) is not a material which simultaneously has conductivity improving properties, if said solid substance (B) is a material that is suitable as an electrode material. From said mass, layers (films) and electrochemical composite layers can be produced that are subsequently impregnated with an electrolyte solution preferably of electrolytes dissolved in plasticizers for said matrix (A).

Abstract: An electrochemical cell with a pair of electrodes arranged as a stack of flat electrode films separated by a separator film, wherein electrode films of each electrode are electrically connected with each other through inner electrode conductors, the inner electrode conductors of the different electrodes are arranged on opposite sides of the electrochemical cell in electrode material-free area of the electrode films, each inner electrode conductor is connected with a separate inner conductor element through a predetermined number of weld points integrated in the electrode material-free area of the respective electrode.

Abstract: The present invention relates to a catalyst for the hydrogenation of unsaturated hydrocarbons, in particular aromatics with a broad molecular weight range, a process for the production thereof and a process for hydrogenating unsaturated hydrocarbons.

Abstract: An electrochemical cell with a pair of electrodes arranged as a stack of flat electrode films separated by a separator film, wherein: electrode films of each electrode are electrically connected with each other through inner electrode conductors, the inner electrode conductors of the different electrodes are arranged on opposite sides of the electrochemical cel in electrode material-free area of the electrode films, each inner electrode conductor is connected with the respective electrode films through a predetermined number of weld points in the electrode material-free area of the respective electrode, each inner electrode conductor includes a predetermined number of openings in which coupling elements are set to connect the inner electrode conductor with an outward electrode conductor for the respective electrode.

Abstract: A method is disclosed for inducing cell-mediated immunity against cellular antigens. More specifically, the invention provides for a method for inducing cytotoxic T-lymphocyte immunity against weak antigens, notably self-proteins. The method entails that antigen presenting cells are induced to present at least one CTL epitope of the weak antigen and at the same time presenting at least one foreign T-helper lymphocyte epitope. In a preferred embodiment, the antigen is a cancer specific antigen, e.g. PSM, Her2, or FGF8b. The method can be exercised by using traditional polypeptide vaccination, but also by using live attenuated vaccines or nucleic acid vaccination. The invention furthermore provides immunogenic analogues of PSM, Her2 and FGF8b, as well as nucleic acid molecules encoding these analogues. Also vectors and transformed cells are disclosed. The invention also provides for a method for identification of immunogenic analogues of weak or non-immunogenic antigens.

Abstract: A method is disclosed for inducing cell-mediated immunity against cellular antigens. More specifically, the invention provides for a method for inducing cytotoxic T-lymphocyte immunity against weak antigens, notably self-proteins. The method entails that antigen presenting cells are induced to present at least one CTL epitope of the weak antigen and at the same time presenting at least one foreign T-helper lymphocyte epitope. In a preferred embodiment, the antigen is a cancer specific antigen, e.g. PSM, Her2, or FGF8b. The method can be exercised by using traditional polypeptide vaccination, but also by using live attenuated vaccines or nucleic acid vaccination. The invention furthermore provides immunogenic analogues of PSM, Her2 and FGF8b, as well as nucleic acid molecules encoding these analogues. Also vectors and transformed cells are disclosed. The invention also provides for a method for identification of immunogenic analogues of weak or non-immunogenic antigens.

Abstract: An electrochemical cell with a cathode electrode and an anode electrode separated by a separator, whereby: the cathode electrode includes at least a two-phase active material based on a lithium-transition metal oxide, and the anode electrode includes at least such a material that the anode electrode has an open circuit voltage curve with a total travel of at least 0.7 V and a steep voltage discharge curve without a saddle point.

Abstract: An energy storage assembly with a plurality of flat electrochemical cells, each of them includes a pair of electrodes which electrically connect the electrochemical cells with each other through outward electrode terminals, wherein each electrochemical cell includes as a pair of outward electrode terminals a straight outward terminal and a curved outward terminal, the electrochemical cells are connected with each other that a straight outward terminal of one of the electrochemical cell is connected with a curved outward terminal of an adjacent electrochemical cell.

Abstract: An energy storage cell having a flexible envelope, which cell is attached flat to a heat-conducting plate.

Abstract: Disclosed are novel methods and compositions for combating diseases characterized by deposition of amyloid. The methods generally rely on immunization against amyloid precursor protein (APP) or beta amyloid (A?). Immunization is preferably effected by administration of analogues of autologous APP or A?, said analogues being capable of inducing antibody production against the autologous amyloidogenic polypeptides. Especially preferred as an immunogen is autologous A? which has been modified by introduction of one single or a few foreign, immunodominant and promiscuous T-cell epitopes. Such methods and means include methods for the preparation of analogues and pharmaceutical formulations, as well as nucleic acid fragments, vectors, transformed cells, polypeptides and pharmaceutical formulations.

Abstract: A process for the preparation of a catalyst, which process comprises the steps of: i) mixing an alumina precursor with combustible carbon-containing fibers with a diameter in the range of from 0.5 to 5 ?m and a length of no greater than 100 ?m in an amount in the range of from 20 to 40 wt % based on the total dry mixture; ii) adding nitric acid and water to form an extrudable mass; iii) extruding the mixture to form shaped particles; iv) drying the shaped particles; v) heating the particles in an atmosphere comprising no more than 5 vol % oxygen at a temperature in the range of from 350 to 600° C.; and vi) then heating the particles in a gas mixture comprising at least 12 vol % oxygen at a temperature in the range of from 450 to 600° C.

Abstract: Disclosed are novel methods for combating diseases characterized by deposition of amyloid. The methods generally rely on immunization against amyloidogenic proteins (proteins contributing to formation of amyloid) such as beta amyloid (A?). Immunization is preferably effected by administration of analogues of autologous amyloidogenic polypeptides, said analogues being capable of inducing antibody production against the autologous amyloidogenic polypeptides. Especially preferred as an immunogen is autologous A? which has been modified by introduction of one single or a few foreign, immunodominant and promiscuous T-cell epitopes while substantially preserving the majority of A?'s B-cell epitopes. Also disclosed are nucleic acid vaccination against amyloidogenic polypeptides and vaccination using live vaccines as well as methods and means useful for the vaccination.

Abstract: The invention relates to a paste-like mass that can be used in electrochemical structural elements, including a heterogeneous mixture of (1.) a matrix (A) containing at least one organic polymer, precursors thereof, or prepolymers thereof, and a plasticizer, and (2.) an electrochemically activatable inorganic material in the form of a solid substance (B), the material not being soluble in the matrix and in water, with the proviso that a conductor that is soluble in the plasticizer and that is different from (B) is not present in the mixture, wherein the plasticizer is present in a quantity of up to about 5% by weight, relative to the quantity of the electrochemically activatable material. Self-supporting layers or layers that are placed on a substrate can be prepared from the paste-like mass.

Abstract: The present invention provides a method for combining the advantages of encoded molecule fragments made by split and mix synthesis with the advantages of template directed synthesis of molecules.

Abstract: The invention relates to a pasty material that can be used in electrochemical components comprising (A) 0-70 percent by weight of a matrix containing at least one organic polymer, its precursors or its prepolymers or consisting thereof; (B) 30-100 percent by weight of inorganic material that can be electrochemically activated and that is preferably nonsoluble in the matrix in the form of a solid substance and optionally a suspending agent for (B). The invention is characterized in that the electrochemically activatable material is at least partially a nanocrystalline powder, with the proviso that material (B) is not a material that can be used as electrode material in the absence of (A). Said material is suitable for producing self-supporting layers or layers placed on a substrate, from which or with which layered composites with electrochemical properties such as accumulators, batteries, condensers (supercaps), solar cells and electrochrome display elements can be produced.

Abstract: The invention relates to highly active spherical metal support catalysts with a metal content of 10 to 70% by mass, and a process for their production with the use of a mixture of polysaccharides and at least one metal compound which is dropped into a metal salt solution.

Abstract: Disclosed are novel methods for combating diseases characterized by deposition of amyloid. The methods generally rely on immunization against amyloidogenic proteins (proteins contributing to formation of amyloid) such as beta amyloid (A?). Immunization is preferably effected by administration of analogues of autologous amyloidogenic polypeptides, said analogues being capable of inducing antibody production against the autologous amyloidogenic polypeptides. Especially preferred as an immunogen is autologous A? which has been modified by introduction of one single or a few foreign, immunodominant and promiscuous T-cell epitopes while substantially preserving the majority of A?'s B-cell epitopes. Also disclosed are nucleic acid vaccination against amyloidogenic polypeptides and vaccination using live vaccines as well as methods and means useful for the vaccination.

Abstract: A hybrid motor vehicle (1) with an electric energy storage unit (2) is designed to enable the improvement of the power output and to increase the service life of the energy storage unit (2). For this purpose, thermal insulation (4) is provided according to the invention.